IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $224,805 | +19.6% | 10,500 | 0.0% | 0.09% | +6.8% |
| Q3 2022 | $188,000 | +86.1% | 10,500 | 0.0% | 0.09% | +87.2% |
| Q2 2022 | $101,000 | -42.9% | 10,500 | 0.0% | 0.05% | -37.3% |
| Q1 2022 | $177,000 | +0.6% | 10,500 | 0.0% | 0.08% | +7.1% |
| Q4 2021 | $176,000 | +2.9% | 10,500 | 0.0% | 0.07% | -10.3% |
| Q3 2021 | $171,000 | +159.1% | 10,500 | 0.0% | 0.08% | +160.0% |
| Q2 2021 | $66,000 | +1.5% | 10,500 | 0.0% | 0.03% | -37.5% |
| Q1 2021 | $65,000 | -5.8% | 10,500 | +5.0% | 0.05% | +29.7% |
| Q4 2020 | $69,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |